Dan has over 16 years experience in corporate and business development roles at life science and molecular diagnostics companies, including Sequenom, Genoptix (Novartis), Natera and most recently Berkeley Lights. He has led over 100 strategic transactions, on both the buy- and sell-side, and has developed successful corporate strategies for small- and medium-sized biotechnology companies with disruptive technologies. He has a BS and MS in Biology from UCSD and a MBA from London Business School.